Loading...

Sumitomo Pharma Co., Ltd.

DNPUF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$8.97
$0.00(0.00%)

Sumitomo Pharma Co., Ltd. (DNPUF) Stock Overview

Explore Sumitomo Pharma Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.2/100

Key Financials

Market Cap3.6B
P/E Ratio22.30
EPS (TTM)$0.40
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Week$6.53
1 Month$6.87
3 Months$5.91
1 Year Target$2.01

DNPUF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sumitomo Pharma Co., Ltd. (DNPUF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 97.10, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $2.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.30 and a market capitalization of 3.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-13.04%
1-Month Change
-20.00%
3-Month Change
N/A
6-Month Change
-6.98%
Year-to-Date (YTD) Change
-3.15%
1-Year Change
53.85%
3-Year Change
-60.86%
5-Year Change
-69.11%
All-Time (Max) Change
-47.40%

Contact Information

https://www.sumitomo-pharma.com
81 6 6203 5321
6-8, Doshomachi 2-chome, Osaka, 541-0045

Company Facts

4,980 Employees
IPO DateJan 17, 2012
CountryJP
Actively Trading

Frequently Asked Questions

;